OTCMKTS:CDBT China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis $0.06 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About China Dasheng Biotechnology Stock (OTCMKTS:CDBT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CDBT alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0652-Week Range$0.00▼$0.15VolumeN/AAverage Volume12,561 shsMarket Capitalization$2.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China. Read More Receive CDBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Dasheng Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDBT Stock News HeadlinesChina Dasheng Biotechnology Co.: CDBT'S Transport Operations ExpandJune 5, 2023 | finanznachrichten.deCDBT'S Transport Operations ExpandJune 5, 2023 | finance.yahoo.comInside the Options Play With a High Historical Win RateIan Cooper's newest strategy targets triple-digit returns in just 9 days. It doesn't work every time, but a 73% win rate and 2,671% return on capital stand on their own. Ian is breaking down the full strategy and offering his newest report at no charge.October 8 at 1:00 AM | TradeWins (Ad)CDBT to acquire Cycclone Magnetic EnginesApril 24, 2023 | seekingalpha.comChina Dasheng Biotechnology Co.: CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine ProjectApril 24, 2023 | finanznachrichten.deCycclone Magnetic Engines Acknowledges Embezzlement Allegations Against Cameron James Smith in their Transport HoldingsApril 20, 2023 | finance.yahoo.comChina Dasheng Biotechnology Company (CDBT)March 9, 2023 | finance.yahoo.comChina Dasheng Biotechnology Co.February 24, 2023 | barrons.comSee More Headlines CDBT Stock Analysis - Frequently Asked Questions How have CDBT shares performed this year? China Dasheng Biotechnology's stock was trading at $0.0390 at the start of the year. Since then, CDBT stock has increased by 53.8% and is now trading at $0.06. How do I buy shares of China Dasheng Biotechnology? Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of China Dasheng Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that China Dasheng Biotechnology investors own include Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU). Company Calendar Today10/08/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMaterials Industry Drug stores & proprietary stores Sub-IndustryRetail Current SymbolOTCMKTS:CDBT CIKN/A WebN/A Phone(424) 358-1046Fax86-93-1844-1248Employees689Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares40,976,000Free FloatN/AMarket Cap$2.46 million OptionableNot Optionable Beta2.25 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:CDBT) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersHOST Just Entered the AI Data Center Race in a BIG WayHost Digital Inc (NYSE American: HOST) has completed its merger with Healthy Choice Wellness Corp as of Septem...Trading Wire | SponsoredOminous New Day in America (Get Ready for it)A market forecaster with a 55-year track record - including calls on 1970s double-digit inflation, the 1980s S...Weiss Ratings | Sponsored$169 Private Jet Trick ExposedFor $169, a growing circle of travelers are booking private jets without the wait, the hassle, or the high pri...International Living | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Dasheng Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share China Dasheng Biotechnology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.